Clinical Benefit and Safety of Reduced Elective Dose in Definitive Radiotherapy for Head and Neck Squamous Cell Carcinoma: The UPGRADE-RT Multicenter Randomized Controlled Trial
This is the second randomized controlled trial demonstrating that reduced elective dose is safe in definitive RT for HNC.
Authors
- Frank Hoebers (ORCID: https://orcid.org/0000-0002-4317-9181)
- Tim Dijkema
- Marije R. Vergeer (ORCID: https://orcid.org/0000-0001-9609-1784)
- Gerjon Hannink (ORCID: https://orcid.org/0000-0001-9526-3775)
- Bas Kreike (ORCID: https://orcid.org/0000-0003-0030-8200)
- Patricia Doornaert (ORCID: https://orcid.org/0000-0002-9475-246X)
- Sven van den Bosch (ORCID: https://orcid.org/0000-0002-0675-1847)
- Maurice C. Cox (ORCID: https://orcid.org/0000-0002-6428-4941)
- Ellen M. Zwijnenburg (ORCID: https://orcid.org/0000-0002-1727-8215)
- Johannes H.A.M. Kaanders (ORCID: https://orcid.org/0000-0001-5374-9558)
Institutions
- Radboud University Nijmegen (NL)
- Radboud University Medical Center (NL)
- University Medical Center Utrecht (NL)
- Maastricht University (NL)
- Radiotherapiegroep (NL)
- Amsterdam University Medical Centers (NL)
Publication Details
- Journal
- Journal of Clinical Oncology
- Published
- 2025-04-15
- DOI
- https://doi.org/10.1200/jco-24-02194
- Citations
- 13
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 24.02